,48 In contrast, in triple negative breast cancer, HORMAD1 suppresses homologous recombination and induces non-homologues end joining repair, hence sensitizing cancer cells to the use of homologous recombination-targeting therapy such as platinum-based chemotherapy.49 The gene discussed is HORMAD1; the disease is cancer.